{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:57:43Z","timestamp":1790661463028,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201084"],"award-info":[{"award-number":["82201084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","award":["2023 MP10"],"award-info":[{"award-number":["2023 MP10"]}],"id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M722232"],"award-info":[{"award-number":["2022M722232"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005024","name":"Beijing Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023-ZZ-020"],"award-info":[{"award-number":["2023-ZZ-020"]}],"id":[{"id":"10.13039\/501100005024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2023.e23216","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T14:33:30Z","timestamp":1702391610000},"page":"e23216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Research hotspots and emerging trends in the treatment of Sjogren's syndrome: A bibliometric analysis from 1900 to 2022"],"prefix":"10.1016","volume":"10","author":[{"given":"Wenpeng","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.heliyon.2023.e23216_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41584-021-00634-x","article-title":"Current and future therapies for primary sj\u00f6gren syndrome","volume":"17","author":"Seror","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","article-title":"Sj\u00f6gren's syndrome: a systemic autoimmune disease","volume":"22","author":"Negrini","year":"2022","journal-title":"Clin. Exp. Med."},{"issue":"20","key":"10.1016\/j.heliyon.2023.e23216_bib3","first-page":"354","article-title":"The diagnosis and treatment of sj\u00f6gren's syndrome","volume":"114","author":"Stefanski","year":"2017","journal-title":"Deutsches Arzteblatt international"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23216_bib4","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary sj\u00f6gren's syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"Eular recommendations for the management of sj\u00f6gren's syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.heliyon.2023.e23216_bib6","first-page":"14","article-title":"Systematic review with meta-analysis: efficacy and safety of biological treatment on salivary gland function in primary sj\u00f6gren\u2019s syndrome","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23216_bib7","first-page":"261","article-title":"Novel approaches for rescuing function of the salivary gland epithelium in primary sj\u00f6gren's syndrome","volume":"38","author":"Wang","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.heliyon.2023.e23216_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.979675","article-title":"Global trends in research on oxidative stress associated with periodontitis from 1987 to 2022: a bibliometric analysis","volume":"13","author":"Xin","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23216_bib9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/phar.1586","article-title":"A descriptive and historical review of bibliometrics with applications to medical sciences","volume":"35","author":"Thompson","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23216_bib10","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s10067-022-06196-x","article-title":"Mapping theme trends and knowledge structure of sj\u00f6gren's syndrome (ss), a bibliometric analysis from 2010 to 2021","volume":"41","author":"Liu","year":"2022","journal-title":"Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23216_bib11","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00296-022-05138-9","article-title":"Research on primary sj\u00f6gren's syndrome in 2004-2021: a web of science-based cross-sectional bibliometric analysis","volume":"42","author":"Chen","year":"2022","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23216_bib12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00296-020-04714-1","article-title":"Publication activity in the field of sj\u00f6gren's syndrome: a ten-year web of science based analysis","volume":"41","author":"Akyol","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23216_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/inm.13085","article-title":"Medical decision-making for adolescents with depression: a bibliometric study and visualization analysis via Citespace","volume":"32","author":"Hua","year":"2023","journal-title":"Int. J. Ment. Health Nurs."},{"key":"10.1016\/j.heliyon.2023.e23216_bib14","volume":"vol. 178","author":"Zhan","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e23216_bib15","series-title":"Searching for Intellectual Turning Points: Progressive Knowledge Domain Visualization","author":"Chen","year":"2004"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23216_bib16","first-page":"57","article-title":"Citespace ii: detecting and visualizing emerging trends and transient patterns in scientific literature","author":"Chen","year":"2006","journal-title":"J. Am. Soc. Inf. Sci. Technol."},{"key":"10.1016\/j.heliyon.2023.e23216_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113932","article-title":"Frontier and hot topics in electrochemiluminescence sensing technology based on Citespace bibliometric analysis","volume":"201","author":"Liu","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.heliyon.2023.e23216_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102846","article-title":"Bibliometric analysis of mental Health during the covid-19 pandemic","volume":"65","author":"Chen","year":"2021","journal-title":"Asian journal of psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2023.e23216_bib19","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1073\/pnas.0307513100","article-title":"Searching for intellectual turning points: progressive knowledge domain visualization","volume":"101","author":"Chen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23216_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/asi.22968","article-title":"Patterns of connections and movements in dual-map overlays: a new method of publication portfolio analysis","volume":"65","author":"Chen","year":"2013","journal-title":"Journal of the Association for Information Science and Technology"},{"key":"10.1016\/j.heliyon.2023.e23216_bib21","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3389\/fpsyg.2019.02197","article-title":"A scientometric review of rasch measurement: the rise and progress of a specialty","volume":"10","author":"Aryadoust","year":"2019","journal-title":"Front. Psychol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23216_bib22","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1002\/asi.22946","article-title":"Interactive Overlays of Journals and the Measurement of Interdisciplinarity on the Basis of Aggregated Journal\u2013Journal Citations","volume":"64","author":"Leydesdorff","year":"2013","journal-title":"Journal of the American Society for Information Science and Technology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s40001-022-00869-8","article-title":"Global trends and frontiers in research on coronary microvascular dysfunction: a bibliometric analysis from 2002 to 2022","volume":"27","author":"Gao","year":"2022","journal-title":"Eur. J. Med. Res."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23216_bib24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1517\/14712598.2014.920813","article-title":"Emerging trends and new developments in regenerative medicine: a scientometric update (2000 - 2014)","volume":"14","author":"Chen","year":"2014","journal-title":"Expet Opin. Biol. Ther."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23216_bib25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/1570159X18666200905151333","article-title":"A scientometrics analysis and visualization of depressive disorder","volume":"19","author":"Xu","year":"2021","journal-title":"Curr. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23216_bib26","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.4103\/1673-5374.255995","article-title":"Knowledge domain and emerging trends in alzheimer's disease: a scientometric review based on Citespace analysis","volume":"14","author":"Liu","year":"2019","journal-title":"Neural regeneration research"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23216_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of rheumatology classification criteria for sj\u00f6gren's syndrome: a data-driven, expert consensus approach in the sj\u00f6gren's international collaborative clinical alliance cohort","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"American College of rheumatology\/European League against rheumatism classification criteria for primary sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23216_bib29","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.27314","article-title":"Effectiveness of rituximab treatment in primary sj\u00f6gren's syndrome: a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Meijer","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23216_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-1085","article-title":"Treatment of primary sj\u00f6gren syndrome with rituximab: a randomized trial","volume":"160","author":"Devauchelle-Pensec","year":"2014","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23216_bib31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","article-title":"Efficacy and safety of belimumab in primary sj\u00f6gren's syndrome: results of the beliss open-label phase ii study","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23216_bib32","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","article-title":"Rituximab treatment in patients with primary sj\u00f6gren's syndrome: an open-label phase ii study","volume":"52","author":"Pijpe","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23216_bib33","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.40093","article-title":"Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary sj\u00f6gren's syndrome","volume":"69","author":"Bowman","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23216_bib34","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar1912","article-title":"B cell-activating factor of the tumor necrosis factor family (baff) is expressed under stimulation by interferon in salivary gland epithelial cells in primary sj\u00f6gren's syndrome","volume":"8","author":"Ittah","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of baff\/blys overexpression and altered B cell differentiation with sj\u00f6gren's syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23216_bib36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/art.22536","article-title":"Improvement of sj\u00f6gren's syndrome after two infusions of rituximab (anti-Cd20)","volume":"57","author":"Devauchelle-Pensec","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23216_bib37","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary sj\u00f6gren's syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e23216_bib38","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23216_bib39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.heliyon.2023.e23216_bib40","series-title":"What Is Research Collaboration? - Sciencedirect","author":"Katz","year":"1997"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23216_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/dewb.12136","article-title":"Designing research funding schemes to promote global Health equity: an exploration of current practice in Health systems research","volume":"18","author":"Pratt","year":"2018","journal-title":"Develop. World Bioeth."},{"key":"10.1016\/j.heliyon.2023.e23216_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.maturitas.2020.05.018","article-title":"The world Health organization (who) approach to healthy ageing","volume":"139","author":"Rudnicka","year":"2020","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cger.2016.08.007","article-title":"Sj\u00f6gren syndrome and other causes of sicca in older adults","volume":"33","author":"Baer","year":"2017","journal-title":"Clin. Geriatr. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23216_bib44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7150\/ijms.17718","article-title":"Reviewing primary sj\u00f6gren's syndrome: beyond the dryness - from pathophysiology to diagnosis and treatment","volume":"14","author":"Both","year":"2017","journal-title":"Int. J. Med. Sci."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23216_bib45","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","article-title":"Advances in understanding the pathogenesis of primary sj\u00f6gren's syndrome","volume":"9","author":"Nocturne","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23216_bib46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/imt.13.49","article-title":"The future of B cell-targeted therapies in sj\u00f6gren's syndrome","volume":"5","author":"Cornec","year":"2013","journal-title":"Immunotherapy"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23216_bib47","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","article-title":"Efficacy of rituximab in systemic manifestations of primary sjogren's syndrome: results in 78 patients of the autoimmune and rituximab registry","volume":"72","author":"Gottenberg","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23216_bib48","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2007.083865","article-title":"Reduction of fatigue in sj\u00f6gren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study","volume":"67","author":"Dass","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23216_bib49","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/art.39088","article-title":"Brief Report: ultrasonographic assessment of salivary gland response to rituximab in primary sj\u00f6gren's syndrome","volume":"67","author":"Jousse-Joulin","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23216_bib50","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/rheumatology\/kev005","article-title":"Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary sjogren's syndrome","volume":"54","author":"Pontarini","year":"2015","journal-title":"Rheumatology"},{"issue":"23","key":"10.1016\/j.heliyon.2023.e23216_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163030","article-title":"A randomized, phase ii study of sequential belimumab and rituximab in primary sj\u00f6gren's syndrome","volume":"7","author":"Mariette","year":"2022","journal-title":"JCI insight"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23216_bib52","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2174\/138920112802273092","article-title":"Local activation and systemic dysregulation of T lymphocytes in sj\u00f6gren's syndrome","volume":"13","author":"Busch","year":"2012","journal-title":"Curr. Pharmaceut. Biotechnol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23216_bib53","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/art.40165","article-title":"Attenuation of follicular helper T cell-dependent B cell hyperactivity by abatacept treatment in primary sj\u00f6gren's syndrome","volume":"69","author":"Verstappen","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23216_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/biom10111539","article-title":"Cells subsets in the immunopathology and treatment of sjogren's syndrome","volume":"10","author":"R\u00edos-R\u00edos","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23216_bib55","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/annrheumdis-2020-218599","article-title":"Efficacy and safety of abatacept in active primary sj\u00f6gren's syndrome: results of a phase iii, randomised, placebo-controlled trial","volume":"80","author":"Baer","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23216_bib56","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","article-title":"Abatacept treatment reduces disease activity in early primary sj\u00f6gren's syndrome (Open-Label proof of concept asap study)","volume":"73","author":"Meiners","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23216_bib57","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/acr.22052","article-title":"Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary sj\u00f6gren\u2019s syndrome: a pilot study","volume":"65","author":"Adler","year":"2013","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10067-019-04724-w","article-title":"Effectiveness and safety of abatacept for the treatment of patients with primary sj\u00f6gren's syndrome","volume":"39","author":"Machado","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23216_bib59","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3109\/14397595.2016.1158773","article-title":"Effectiveness of abatacept for patients with sj\u00f6gren's syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: rose (rheumatoid arthritis with orencia trial toward sj\u00f6gren's syndrome endocrinopathy) trial","volume":"26","author":"Tsuboi","year":"2016","journal-title":"Mod. Rheumatol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23216_bib60","article-title":"Abatacept treatment for patients with early active primary sjgren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (Asap-Iii study)","volume":"2","author":"Jfvn","year":"2020","journal-title":"The Lancet Rheumatology"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23216_bib61","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ni.3748","article-title":"The transcriptional coactivator taz regulates reciprocal differentiation of T(H)17 cells and T(reg) cells","volume":"18","author":"Geng","year":"2017","journal-title":"Nat. Immunol."},{"issue":"24","key":"10.1016\/j.heliyon.2023.e23216_bib62","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015952","article-title":"Th17\/Treg cell level and clinical characteristics of peripheral blood of patients with sjogren's syndrome complicated with primary biliary cirrhosis","volume":"98","author":"Hao","year":"2019","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib63","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s13287-021-02541-0","article-title":"Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine sj\u00f6gren's syndrome by modulating the balance of Treg and Th17 cells","volume":"12","author":"Li","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/1756-185X.13962","article-title":"Interleukin-35 regulates the balance of Th17 and Treg responses during the pathogenesis of connective tissue diseases","volume":"24","author":"Wang","year":"2021","journal-title":"International journal of rheumatic diseases"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23216_bib65","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/annrheumdis-2018-213036","article-title":"Short-term and low-dose il-2 therapy restores the Th17\/treg balance in the peripheral blood of patients with primary sj\u00f6gren's syndrome","volume":"77","author":"Miao","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23216_bib66","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00011-022-01600-3","article-title":"Mait cells and their implication in human oral diseases","volume":"71","author":"Jiang","year":"2022","journal-title":"Inflamm. Res. : official journal of the European Histamine Research Society [et al"},{"key":"10.1016\/j.heliyon.2023.e23216_bib67","article-title":"Emerging roles of mucosal-associated invariant T cells in rheumatology","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23216_bib68","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/eji.201747140","article-title":"Il-17 polarization of mait cells is derived from the activation of two different pathways","volume":"47","author":"Guggino","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23216_bib69","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/eji.201646300","article-title":"Mucosal-associated invariant T cells are reduced and functionally immature in the peripheral blood of primary sj\u00f6gren's syndrome patients","volume":"46","author":"Wang","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23216_bib70","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1141","article-title":"Plasmacytoid dendritic cells in immunity","volume":"5","author":"Colonna","year":"2004","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23216_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020251","article-title":"The role of interferons in the pathogenesis of sj\u00f6gren's syndrome and future therapeutic perspectives","volume":"11","author":"Del Papa","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23216_bib72","first-page":"212","article-title":"Pivotal functions of plasmacytoid dendritic cells in systemic autoimmune pathogenesis","volume":"5","author":"Cao","year":"2014","journal-title":"J. Clin. Cell. Immunol."},{"key":"10.1016\/j.heliyon.2023.e23216_bib73","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fimmu.2013.00290","article-title":"Interferons in sj\u00f6gren's syndrome: genes, mechanisms, and effects","volume":"4","author":"Li","year":"2013","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23216_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166302","article-title":"Plasmacytoid dendritic cells promote the pathogenesis of sj\u00f6gren's syndrome","volume":"1868","author":"Zhou","year":"2022","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.heliyon.2023.e23216_bib75","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3389\/fimmu.2019.02096","article-title":"Plasmacytoid dcs from patients with sj\u00f6gren's syndrome are transcriptionally primed for enhanced pro-inflammatory cytokine production","volume":"10","author":"Hillen","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib76","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/art.41489","article-title":"Improvement of severe fatigue following nuclease therapy in patients with primary sj\u00f6gren's syndrome: a randomized clinical trial","volume":"73","author":"Posada","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23216_bib77","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/1744666X.2019.1624527","article-title":"Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for sj\u00f6gren's syndrome","volume":"15","author":"van der Heijden","year":"2019","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.heliyon.2023.e23216_bib78","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2018.02.001","article-title":"Tbk1: a key regulator and potential treatment target for interferon positive sj\u00f6gren's syndrome, systemic lupus erythematosus and systemic sclerosis","volume":"91","author":"Bodewes","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.heliyon.2023.e23216_bib79","article-title":"Mesenchymal stem cells in primary sj\u00f6gren's syndrome: prospective and challenges","volume":"2018","author":"Chen","year":"2018","journal-title":"Stem Cell. Int."},{"issue":"16","key":"10.1016\/j.heliyon.2023.e23216_bib80","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1089\/scd.2017.0045","article-title":"Characteristics of labial gland mesenchymal stem cells of healthy individuals and patients with sj\u00f6gren's syndrome: a preliminary study","volume":"26","author":"Wang","year":"2017","journal-title":"Stem Cell. Dev."},{"issue":"22","key":"10.1016\/j.heliyon.2023.e23216_bib81","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1089\/scd.2017.0161","article-title":"Effect of bone morphogenetic protein 6 on immunomodulatory functions of salivary gland-derived mesenchymal stem cells in sj\u00f6gren's syndrome","volume":"27","author":"Xu","year":"2018","journal-title":"Stem Cell. Dev."},{"issue":"19","key":"10.1016\/j.heliyon.2023.e23216_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910474","article-title":"Treatment of sj\u00f6gren's syndrome with mesenchymal stem cells: a systematic review","volume":"22","author":"Chihaby","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib83","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/rheumatology\/keu292","article-title":"In Vitro immunomodulatory effects of microencapsulated umbilical cord wharton jelly-derived mesenchymal stem cells in primary sj\u00f6gren's syndrome","volume":"54","author":"Alunno","year":"2015","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib84","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13287-022-02993-y","article-title":"Organ-specific extracellular matrix directs trans-differentiation of mesenchymal stem cells and formation of salivary gland-like organoids in vivo","volume":"13","author":"Tran","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.heliyon.2023.e23216_bib85","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jdsr.2021.03.002","article-title":"Application of regenerative medicine to salivary gland hypofunction","volume":"57","author":"Tanaka","year":"2021","journal-title":"The Japanese dental science review"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib86","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/stem.2455","article-title":"Concise review: salivary gland regeneration: therapeutic approaches from stem cells to tissue organoids","volume":"35","author":"Lombaert","year":"2017","journal-title":"Stem Cell."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23216_bib87","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.archoralbio.2013.02.015","article-title":"Treatment of salivary gland hypofunction by transplantation with dental pulp cells","volume":"58","author":"Yamamura","year":"2013","journal-title":"Arch. Oral Biol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23216_bib88","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/rheumatology\/keaa012","article-title":"Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary sj\u00f6gren's syndrome","volume":"59","author":"Wang","year":"2020","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib89","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/art.40659","article-title":"Salivary gland stem cells age prematurely in primary sj\u00f6gren's syndrome","volume":"71","author":"Pringle","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.heliyon.2023.e23216_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121741","article-title":"High-efficient engineering of osteo-callus organoids for rapid bone regeneration within one month","volume":"288","author":"Xie","year":"2022","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23216_bib91","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molmed.2017.02.007","article-title":"Disease modeling in stem cell-derived 3d organoid systems","volume":"23","author":"Dutta","year":"2017","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib92","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1038\/s41467-018-06469-7","article-title":"Generation of orthotopically functional salivary gland from embryonic stem cells","volume":"9","author":"Tanaka","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e23216_bib93","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41556-022-01007-6","article-title":"Human induced pluripotent stem cell-derived salivary gland organoids model sars-cov-2 infection and replication","volume":"24","author":"Tanaka","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"6 Pt 1","key":"10.1016\/j.heliyon.2023.e23216_bib94","first-page":"G1146","article-title":"Direct in vivo adenovirus-mediated gene transfer to salivary glands","volume":"266","author":"Mastrangeli","year":"1994","journal-title":"Am. J. Physiol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23216_bib95","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1517\/14712598.2015.1064894","article-title":"Advances in salivary gland gene therapy - oral and systemic implications","volume":"15","author":"Baum","year":"2015","journal-title":"Expet Opin. Biol. Ther."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23216_bib96","doi-asserted-by":"crossref","first-page":"R172","DOI":"10.1186\/ar3925","article-title":"Gene therapy using il-27 ameliorates sj\u00f6gren's syndrome-like autoimmune exocrinopathy","volume":"14","author":"Lee","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib97","first-page":"86","article-title":"[Transcatheter delivery of recombinant adenovirus vector containing exogenous aquaporin gene in treatment of sj\u00f6gren's syndrome]","volume":"45","author":"He","year":"2016","journal-title":"Zhejiang da xue xue bao Yi xue ban = Journal of Zhejiang University Medical sciences"},{"issue":"20","key":"10.1016\/j.heliyon.2023.e23216_bib98","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.1601992113","article-title":"Aquaporin gene therapy corrects sj\u00f6gren's syndrome phenotype in mice","volume":"113","author":"Lai","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"17","key":"10.1016\/j.heliyon.2023.e23216_bib99","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1089\/104303403322542257","article-title":"Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of sj\u00f6gren's syndrome","volume":"14","author":"Kok","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.heliyon.2023.e23216_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of aav gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2023.e23216_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.10.005","article-title":"Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications","volume":"132","author":"Hartman","year":"2008","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23216_bib102","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.coms.2013.09.007","article-title":"The role of parotidectomy in sj\u00f6gren's syndrome","volume":"26","author":"Madero-Visbal","year":"2014","journal-title":"Oral Maxillofac. Surg. Clin."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23216_bib103","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jcms.2015.06.036","article-title":"Endoscopic management of salivary gland obstructive diseases in patients with sj\u00f6gren's syndrome","volume":"43","author":"De Luca","year":"2015","journal-title":"Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23216_bib104","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.joms.2015.12.019","article-title":"Sialendoscopy of salivary glands affected by sj\u00f6gren syndrome: a randomized controlled pilot study","volume":"74","author":"Jager","year":"2016","journal-title":"J. Oral Maxillofac. Surg. : official journal of the American Association of Oral and Maxillofacial Surgeons"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23216_bib105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00106-009-2076-z","article-title":"[Stenosis and other non-sialolithiasis-related obstructions of the major salivary gland ducts. Modern treatment concepts]","volume":"58","author":"Koch","year":"2010","journal-title":"HNO"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23216_bib106","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1288\/00005537-198503000-00011","article-title":"Sjogren's syndrome: a persistent clinical problem","volume":"95","author":"Bone","year":"1985","journal-title":"Laryngoscope"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23216_bib107","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1288\/00005537-199012000-00004","article-title":"The surgical management of chronic parotitis","volume":"100","author":"Arriaga","year":"1990","journal-title":"Laryngoscope"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23216_bib108","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrrheum.2016.100","article-title":"Treatment of primary sj\u00f6gren syndrome","volume":"12","author":"Saraux","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23216_bib109","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/ard.2007.074203","article-title":"Exocrine function in primary sj\u00f6gren syndrome: natural course and prognostic factors","volume":"67","author":"Haldorsen","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23216_bib110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jtos.2014.12.001","article-title":"Clinical guidelines for management of dry eye associated with sj\u00f6gren disease","volume":"13","author":"Foulks","year":"2015","journal-title":"Ocul. Surf."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23216_bib111","article-title":"Over the counter (otc) artificial tear drops for dry eye syndrome","author":"Pucker","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23216_bib112","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/rheumatology\/kez142","article-title":"Treatment of sj\u00f6gren's syndrome: current therapy and future directions","volume":"60","author":"Fox","year":"2021","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23216_bib113","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rdc.2016.03.009","article-title":"Sj\u00f6gren syndrome: why do clinical trials fail?","volume":"42","author":"Fox","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023104245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023104245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:59:46Z","timestamp":1790657986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023104245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844023104245"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23216","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research hotspots and emerging trends in the treatment of Sjogren's syndrome: A bibliometric analysis from 1900 to 2022","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e23216"}}